छोड़कर सामग्री पर जाएँ

Eris Lifesciences acquires 51% in Swiss Parenterals for Rs 637 crore

This deal also marks the entry of Eris into the RoW Export Markets.

Read More

​ This deal also marks the entry of Eris into the RoW Export Markets. This deal also marks the entry of Eris into the RoW Export Markets.  Moneycontrol Latest News Read More  

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी